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Abstract
Under normal conditions function of the right ventricle (RV) is determined by the heart rhythm, 
RV filling time, RV systolic synchrony and interdependence between both ventricles. Failure of 
the left ventricle (LV) can lead to RV failure. Impaired function of the RV significantly worsens 
the prognosis in patients after myocardial infarction and with LV failure. Permanent atrial 
fibrillation (AF) is one of the most common arrhythmia in patients with depressed RV function. 
Frequent coexistence of chronic heart failure (CHF) and AF causes overlapping of the arrhyth-
mia and RV dysfunction in the setting of CHF. They may lead to hemodynamic compromise 
and worsen prognosis in patients with chronic RV failure of various etiologies. RV structure 
and function can be assessed in 2D, 3D echocardiography, cardiac magnetic resonance ima-
ging and computed tomography. (Cardiol J 2013; 20, 3: 220–226)
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Introduction
Dysfunctions of both ventricles often coexist 
in chronic heart failure (CHF) patients. Left ven-
tricular (LV) failure can lead to right ventricular 
(RV) dysfunction. Occurrence of RV failure wors-
ens prognosis in patients with dysfunctional LV. 
The aim of this paper is to reflect current reference 
on RV performance as a consequence of deve-
loping CHF and atrial fibrillation (AF). Existing 
dysfunction or exposure to RV overload can be 
a substrate for AF occurrence as well. Factors that 
determine RV function under normal conditions 
and as a consequence of developing CHF and/or 
AF are discussed below. Methods of right heart 
imaging are presented. The role of RV function 
at different stages of CHF seems to be underesti-
mated and little attention has been paid so far to 
its function in AF.
Right ventricular function  
under normal conditions
Function of the RV depends on its structure 
and myofibers architecture. The ventricle is trian-
gular or crescent-shaped and is built of the inlet, 
the apical myocardium and the outlet tract. Its 
relatively thin myocardium is composed of a super-
ficial circumferential layer, which continues to the 
LV, and a deep longitudinal layer which facilitates 
shortening of the ventricle in its long axis during 
the systole. Other mechanisms that enable RV 
contraction are concentric inwards motion of the 
free wall and traction on the superficial fibers of the 
free wall secondary to the systole of the LV [1–3].
Due to elastance of the thin RV myocardium 
and low resistance of highly distensible pulmonary 
vessels, pressures in the right side of the heart are 
significantly lower and the RV is more dependent 
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on the afterload than the LV. Preload determines 
function of both ventricles [3–5].
Beside the preload, afterload and muscle con-
tractility, RV function is determined by the heart 
rhythm, RV filling time, RV systolic synchrony 
and interdependence between both ventricles. 
Maintenance of sinus rhythm and atrio-ventricular 
synchrony is crucial for RV function especially in 
chronic RV failure and acute RV infarction [1, 4]. 
It was shown, that preserved function of both atria 
affects the RV more than the LV [2]. Ventricular 
interdependence is mainly dependent on function 
of the intraventricular septum. Studies in animal 
models proved that from 20% to 40% of systolic 
volume and pressure of the RV are generated by 
the LV systole. Diastolic interdependence is sig-
nificantly marked under pathological conditions 
when volume or pressure overloaded RV shifts the 
intraventricular septum into the LV chamber and 
reduces the LV preload and cardiac output. On the 
other hand, volume or pressure of overloaded LV 
causes pressure increase in the RV [1, 6].
Right ventricular function  
in chronic heart failure
Ventricular interdependence implies the fact 
that dysfunctions of both ventricles often coexist. LV 
failure can lead to development of RV failure. On the 
other hand, impaired function of the RV significantly 
worsens the prognosis in patients with LV failure after 
myocardial infarction (MI) [5, 7]. Substudy from the 
VALIANT ECHO study in a group of 600 patients 
after MI with LV dysfunction demonstrated that 
decreased RV function prognoses worse outcome. 
Patients with reduced RV fractional area change 
(RVFAC) were at higher risk of all-cause mortality, 
death from cardiovascular events and sudden death. 
Additionally, they were more prone to develop CHF 
and were at higher risk of stroke than control indi-
viduals. Each 5% decrease in baseline RVFAC was 
associated with a 1.53 (95% CI 1.24–1.88) increased 
risk of fatal and nonfatal cardiovascular outcomes 
[8]. Substudy from the SAVE study in subjects af-
ter MI with impaired LV function showed that RV 
dysfunction was an independent risk factor of total 
mortality, cardiovascular mortality and occurrence 
of CHF. Each 5% reduction in the RVFAC resulted 
in 16% increased odds of cardiovascular mortality 
[9]. Other studies showed, that in patients with 
advanced CHF and LV ejection fraction (LVEF) 
< 40% prognosis strongly depends on RV function. 
RV function influenced the total outcome in these 
patients more significantly than LV function [10, 11].
Coexistence of CHF and AF is frequent. This 
is mainly due to common pathogenesis of both con-
ditions and the fact that one enhances development 
and triggers symptoms of the other. Thus, in clini-
cal practice both states should often be considered 
and treated together [12–14]. It is estimated that 
AF occurs in up to 50% of patients with CHF 
depending on NYHA class [14]. In patients with 
arrhythmia, LV diastolic function is often worse 
and may result in deterioration of RV function [15]. 
Therefore, frequent coexistence of RV dysfunction 
and AF in the setting of CHF is probable. 
Cardiac resynchronization therapy (CRT) is 
a method of treatment in advanced CHF. It involves 
simultaneous stimulation of the RV and the LV. CRT 
is well established in patients with sinus rhythm. 
According to current guidelines it may be also used 
in patients with permanent AF (IIb/C) [16]. Pa-
tients responding to the CRT experience improve-
ment of the LV function, subsequent clinical status 
and reduction in number of hospitalizations due to 
CHF [17, 18]. Improvement of parameters used for 
evaluation of the LV function is observed: LVEF, 
end-diastolic volume, end-diastolic dimension, end-
-systolic volume and, end-systolic dimension [19]. 
CRT upgrades RV function which can be confirmed 
in the traditional echocardiographic examination 
by Tei-index and tricuspid annual systolic motion 
(TAPSE) evaluation [20–23]. The use of tissue 
Doppler imaging led to similar conclusions [24]. 
Recent studies seem to give a contrary opinion 
on how CRT influences markedly depressed RV 
function. It was proven, that significantly weakened 
RV function predisposes to a lack of improvement 
after CRT in terms of NYHA class, 6-minute 
walking test distance and LVEF [25–27]. On the 
other hand, it was shown that CRT may lead to 
improvement of the RV function regardless of its 
volume and size [27]. 
It is still not clear whether patients with 
AF may benefit from CRT to the same extent 
as the ones without arrhythmia. A  systemic 
meta-analysis of 23 observational studies involved 
7 495 patients with CRT. It showed that AF was 
associated with lower rate of clinical response 
and increased risk of death in comparison to in-
dividuals without AF [28]. Contrary to that, some 
papers suggest that in patients with permanent 
AF treated with CRT a significant clinical impro-
vement, comparable to the sinus rhythm group, 
can be achieved [29–31]. The effect of CRT has not 
been compared between patients with paroxysmal 
and persistent AF. One of few reports regarding 
this subject showed, that CRT leads to similar 
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prognostic, symptomatic and echocardiographic 
benefits in patients with paroxysmal, permanent 
AF and sinus rhythm [32]. On the other hand, 
lower incidence of AF episodes in patients with 
CRT and paroxysmal AF can be achieved as 
a result of improved LV and left atrial function 
[33, 34]. Specific evaluation of the CRT benefit 
in patients with paroxysmal and permanent AF in 
the context of the RV function is lacking.
The right heart in patients  
with atrial fibrillation
Relationship between the dimensions and 
function of the right atrium and occurrence of AF 
is properly documented [35, 36]. Enlargement and 
remodeling of both atria predispose to development 
of AF. Studies using stress echocardiography sho-
wed the prognostic values of the right atrium area 
to maintain sinus rhythm after AF ablation [35]. 
However, on the basis of existing evidence, area 
of the right atrium can be used to assess prognosis 
only in patients with non-valvular AF [36].
RV function in patients with AF is not well de-
fined, although the importance of heart rhythm for 
the RV function is well known [4, 37]. Elongation 
of the cardiac cycle, thus lengthening the RV filling 
time results in diastolic volume increase and conse-
quently in increase in RV ejection fraction (RVEF) 
[4]. Study in a small group of patients showed that in 
permanent AF the RV function presented as RVFAC 
is dependent on the RR interval preceding it and on 
the mean heart rate [37]. In another study in patients 
with paroxysmal and persistent AF RV end-systolic 
diameter was markedly larger than in individuals 
without the arrhythmia (20 ± 2 mm in AF group vs. 
17 ± 2 mm in control group). RVEF in patients with AF 
was deteriorated in comparison to healthy individuals: 
69 ± 8%, 60 ± 11% and 74 ± 3% in paroxysmal, per-
manent and control group, respectively. End-diastolic 
diameter did not differ between the groups [38]. The 
results of this study showed, that level of NT-proBNP, 
which is a marker of cardiac dysfunction, correlated 
with RVEF and was significantly higher in patients 
with permanent AF [39].
Atrial fibrillation in the failing right heart
Atrial tachyarrhythmias are most common 
in patients with depressed RV function. Their 
occurrence may be one of clinical manifestations 
of RV failure [2].
The results of the ACAP-HF Program in 
a group of 900 patients showed that occurence of 
the RV failure in the course of decompensated 
chronic LV failure increases the risk of AF de-
velopment. Weakened RV function was one of 
the strongest predictors of AF occurrence. Two 
thirds of AF cases occurred in patients with RV 
dysfunction. Moreover, patients with RV dysfun-
ction had higher risk of cardiac readmission and 
mortality than control individuals: 4.7%/year vs. 
2.9%/year. Finally, patients with deteriorated RV 
function who developed AF proved to be the ones 
with the worst prognosis in the whole group [40]. 
In patients with RV infarction hemodynamic sta-
bilization depends also on maintenance of sinus 
rhythm [41].
Atrial flutter or AF may also lead to hemo-
dynamic compromise and worsen prognosis in 
patients with chronic RV failure, not only of is-
chemic etiology [2, 42–44]. In pulmonary hyper-
tension the RV is exposed to pressure overload. 
Hemodynamic and clinical stabilization depends 
mainly on its function. In patients with chronic 
pulmonary hypertension persistent AF is asso-
ciated with significantly increased risk of death 
due to RV failure. Occurrence of supraventricular 
arrhythmias is often preceded by deterioration 
of RV function. In one of the studies mortality 
due to RV failure in patients with permanent AF 
was approximately 80%. By contrast, in patients 
in whom sinus rhythm was restored after first 
episode of AF, total mortality was 6% [42].
Observation of patients with congenital heart 
defects showed that abnormalities of RV structure 
predispose to developing atrial arrhythmias more 
than left-sided lesions. In one of the studies, risk of 
development of any atrial arrhythmia was circa 61% 
in the RV-defect group and 55.4% in the LV-defect 
group [43]. An isolated atrial septal defect, if not 
corrected, may cause a long lasting volume over-
load of the RV. The RV tolerates volume overload 
better than pressure overload. Dilatation of its 
cavity tends to normalize within 1–24 months after 
closure of the defect. However, in some patients it 
may last for over 5 years and AF may develop even 
decades after successful closing procedure [44]. 
A large analysis in a group of over 38 000 patients 
with various congenital heart defects affecting 
the right heart showed 15% prevalence of atrial 
arrhythmias in adult patients. Other studies re-
ported from 25% to 30% arrhythmia prevalence. 
Risk factors for AF or other atrial arrhythmia 
development included age, CHF and right atrial 
size. The results of the studies showed that atrial 
arrhythmias are associated with 2.5 fold increased 
risk of morbidity and 50% increased risk of mor-
tality [45, 46].
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Right ventricular pacing and heart failure
RV pacing creates specific clinical conditions 
that affect RV function and may induce AF and CHF 
[47, 48]. As a non-physiological mode of pacing it 
causes a loss of atrio-ventricular systolic synchro-
ny. It has been proven that RV pacing exacerbates 
HF in patients with LVEF < 40% [49]. In post-MI 
patients, RV apical pacing was associated with 
a worsening of LV function, suggesting at the same 
time that among MI survivors, the need for pace-
maker may be a marker of worse outcome [50]. 
Cumulative RV pacing > 2% and EF < 40% are 
independent predictors of ventricular tachycardia/ 
/ventricular fibrillation occurrence, higher morta-
lity rate and HF hospitalizations in patients after 
cardioverter-defibrillator implantation [51]. 
The deleterious effects of RV apical pacing 
have been attributed to the abnormal electrical 
and mechanical activation, secondary to this form 
of pacing. During RV apical pacing, the electrical 
wave front propagates mainly through the myocar-
dium rather than via the His-Purkinje conduction 
system. This is characterized by wave front bre-
akthrough at the interventricular septum and latest 
activation of the infero-posterior base of the LV. 
The paced region contracts early at a time of low 
load, but then it is stretched in systole as the lateral 
wall finally contracts. Asynchronous myocardial 
contraction significantly decreases the stroke 
volume and right-shifts the LV end-systolic pres-
sure – volume relationship. Thus, RV apical pacing 
leads to ventricular dyssynchronization, systolic 
and diastolic ventricular dysfunction, increase of 
wall stress, and energetic inefficiency [52]. It also 
causes interventricular dyssynchronization, as the 
RV contracts earlier than in a physiological model.
It has been proven that right ventricular outlet 
tract (RVOT) pacing can reduce unfavorable effects 
and slow down cardiac remodeling caused by per-
manent RV pacing. In one of the studies clinical 
and echocardiographic benefits observed in the 
RVOT group after 7 years of pacing were reflected 
by lower NT-proBNP concentration in this group 
of patients [53].
CHF, as a result of impaired LV function, has 
been given close attention, but RV function during 
RV pacing still requires further research.
Imaging and assessment of right  
ventricular structure and function
Cardiac magnetic resonance imaging (CMR) 
is a precise method of RV structure and function 
assessment. It enables accurate quantification of 
heart chambers volumes and calculation of myocar-
dial mass from tracing epicardial and endocardial 
borders and multiplying them by myocardial dens-
ity [54]. Valvular regurgitant volumes and shunt 
severity can also be precisely calculated using 
velocity-encoded cine images [55]. Intra-observer 
and inter-observer variability in CMR RV mea-
surements ranges from 3% to 6% and 4% to 9%, 
respectively [56, 57]. Because of its good spatial 
and temporal resolution, CMR-derived volumes 
and EF are considered the gold standard regarding 
other imaging modalities. However, CMR is not 
routinely used because of its still limited availabi-
lity and high costs.
Computed tomography (CT) has also been 
considered a reliable method to assess the RV. 
One of the studies showed, that there was little 
variability between the measurements of RV by 
the two observers (kappa = 0.895–0.980, p < 0.05). 
There was also good correlation between all para-
meters obtained by CT and CMR (p < 0.001): RV 
end-diastolic volume (RVEDV 108.5 ± 21.9 mL, 
113.5 ± 24.8 mL, r = 0.944), RV end-systolic volume 
(RVESV 69.8 ± 33.4 mL, 73.2 ± 35.4 mL, r = 
=0.972), RV systolic volume (RVSV 39.0 ± 13.2 mL, 
40.2 ± 13.3 mL, r = 0.977), RV cardiac output 
(RVCO 2.6 ± 0.7l, 2.6 ± 0.7l, r = 0.958), and there 
was no significant difference between CT and CMR 
measurements in RVEF (38.8 ± 19.1%, 39.1 ± 
± 19.3%, r = 0.990, n = 50, t = –0.677, p > 0.05). 
The results of the study suggest, that 320-slice 
volume cardiac CT is an accurate non-invasive 
technique to evaluate RV function [58]. Other paper 
shows that cardiac CT fully quantifies LV size and 
function. However, RV quantification with cardiac 
CT requires optimized contrast opacification of the 
RV [59]. When compared to radionuclide ventricu-
lography, CT seems to be a reliable method for as-
sessment of the RV as well. It has been shown that 
RVEF can be accurately assessed with ECG-gated 
multidetector computed tomography (MDCT) 
using commercially available software [60].
RV can also be accurately evaluated by echo-
cardiography. Simple and established method for 
determining global RV function in the traditional 
two-dimensional imaging is an evaluation of TAPSE 
measured in M-mode presentation of the apical 
4-chamber view [61]. The method is reliable also 
in patients with AF [62]. Percentage change in the 
surface of the RV (RVFAC) can also be assessed 
[8]. It is possible to calculate the ratio of RV global 
function (MPI, myocardial performance index). 
Additionally, tissue Doppler imaging enables mea-
surement of peak systolic velocity of the tricuspid 
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annulus (S’), which is another complementary 
method for evaluating RV function [63]. RV free 
wall segmental motion and thickening are the 
points of evaluation as well. RV function can be 
assessed by eye-balling (Fig. 1). 
A long-lasting overload of the RV can be indi-
rectly estimated from the main pulmonary artery 
extension, measured in the parasternal short-
-vascular projection. The current flow through 
the pulmonary valve measured with use of pulse 
Doppler wave enables analysis of its spectrum and 
assessment of its acceleration time. Acceleration 
time is shortened when pulmonary arterial pres-
sure is increased, RV systolic function is weakened 
and/or in paradoxical septal contraction occurring 
in acute conditions: acute pulmonary embolism 
and RV MI. 
For the quantification of interventricular 
dyssynchrony, which is a predictor of outcome in 
CRT, conventional Doppler techniques are used. 
The electromechanical delay is calculated as the 
time from the onset of QRS complex to the onset 
of pulmonary systolic flow (RV electromechanical 
delay) or aortic systolic flow (LV electromechanical 
delay). The time difference between RV and LV 
electromechanical delay represents interventri-
cular dyssynchrony [50].
Three-dimensional imaging echocardiography 
is a novel method which allows to obtain more re-
liable data on the structure and function of the RV, 
particularly on its RVESV and RVEDV. Additional-
ly, the RVEF determined by this method shows 
good correlation with measurements in MRI 
[64–66].
According to current guidelines of the Eu-
ropean Society of Echocardiography, assessment 
of the right heart structure should include RV, 
right atrium dimensions and areas in short, long 
parasternal axis and in apical 4-chamber view. RV 
function should be evaluated with use of the above 
mentioned markers of its systolic and diastolic 
function and estimation of EF in the traditional 
2D imaging. In addition, EF in 3D imaging can be 
assessed [67]. Table 1 presents RV dimensions and 
parameters of its function under normal conditions 
according to the guidelines.
Conclusions
RV function is crucial for outcome in patients 
with CHF, especially in patients with significant 
LV dysfunction. Its dysfunction often coexists 
with AF, not only in HF, but also in a number of 
conditions that depress RV acutely or chronically. 
RV structure can be precisely assessed with novel 
modalities of echocardiography, CT and magnetic 
resonance imaging.
Conflict of interest: none declared
Table 1. Reference limits for recommended me-
asures of right heart structure and function (from 
Guidelines for Echocardiographic Assessment 
of the right Heart in Adults: A Report from the 
American Society of Echocardiography) [67].
Abnormal Chamber  
dimensions
RV basal diameter > 4.2 cm
RV subcostal wall thickness > 0.5 cm
RVOT PSAX distal diameter > 2.7 cm
RVOT PLAX proximal diameter > 3.3 cm
RA major dimension > 5.3 cm
RA minor dimension > 4.4 cm
RA end-systolic area > 18 cm2
Systolic function 
TAPSE < 1.6 cm
Pulsed Doppler velocity peak at 
the annulus
< 10 cm/s
Pulsed Doppler MPI > 0.40
Tissue Doppler MPI > 0.55
Fractional area change < 35%
Diastolic function
E/A ratio < 0.8 or > 2.1 
E/E’ ratio > 6
Deceleration time < 120 ms
3-dimensional imaging
RVEF < 44%
RV — right ventricle; RVOT — right ventricular outlet tract; 
PLAX — parasternal long axis; PSAX — parasternal short axis; 
RA — right atrium; TAPSE — tricuspid annulus plane systolic 
excursion; MPI — myocardial performance index; RVEF — right 
ventricular ejection fraction
Figure 1. Right ventricular measurements [68].
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